These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 34066081

  • 1. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
    Kovacikova L, Prnova MS, Majekova M, Bohac A, Karasu C, Stefek M.
    Molecules; 2021 May 12; 26(10):. PubMed ID: 34066081
    [Abstract] [Full Text] [Related]

  • 2. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
    Grewal AS, Bhardwaj S, Pandita D, Lather V, Sekhon BS.
    Mini Rev Med Chem; 2016 May 12; 16(2):120-62. PubMed ID: 26349493
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase inhibitors: 2013-present.
    Quattrini L, La Motta C.
    Expert Opin Ther Pat; 2019 Mar 12; 29(3):199-213. PubMed ID: 30760060
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
    Elmazoglu Z, Prnova MS, Stefek M, Ceylan AF, Aschner M, Rangel-López E, Santamaria A, Karasu C.
    Neurotox Res; 2021 Jun 12; 39(3):588-597. PubMed ID: 33713301
    [Abstract] [Full Text] [Related]

  • 6. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
    Juskova M, Majekova M, Demopoulos V, Stefek M.
    Gen Physiol Biophys; 2011 Dec 12; 30(4):342-9. PubMed ID: 22131315
    [Abstract] [Full Text] [Related]

  • 7. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
    Huang Q, Liu Q, Ouyang D.
    Med Chem; 2019 Dec 12; 15(1):3-7. PubMed ID: 29792152
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.
    Gupta JK.
    Curr Pharm Biotechnol; 2024 Dec 12; 25(9):1073-1081. PubMed ID: 37649296
    [Abstract] [Full Text] [Related]

  • 10. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
    Zhu S, Zhang S, Hao X, Qin X, Parveen S, Yang S, Ma B, Zhu C.
    J Enzyme Inhib Med Chem; 2016 Dec 12; 31(sup1):126-130. PubMed ID: 27153454
    [Abstract] [Full Text] [Related]

  • 11. Potential use of aldose reductase inhibitors to prevent diabetic complications.
    Zenon GJ, Abobo CV, Carter BL, Ball DW.
    Clin Pharm; 1990 Jun 12; 9(6):446-57. PubMed ID: 2114249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M, Snirc V, Djoubissie PO, Majekova M, Demopoulos V, Rackova L, Bezakova Z, Karasu C, Carbone V, El-Kabbani O.
    Bioorg Med Chem; 2008 May 01; 16(9):4908-20. PubMed ID: 18395454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carboxymethylated tetrahydropyridoindoles as aldose reductase inhibitors: in vitro selectivity study in intact rat erythrocytes in relation to glycolytic pathway.
    Juskova M, Snirc V, Gajdosikova A, Gajdosik A, Krizanova L, Stefek M.
    Gen Physiol Biophys; 2009 Dec 01; 28(4):325-30. PubMed ID: 20097954
    [Abstract] [Full Text] [Related]

  • 16. Clinical potential of aldose reductase inhibitors in diabetic neuropathy.
    Hamada Y, Nakamura J.
    Treat Endocrinol; 2004 Dec 01; 3(4):245-55. PubMed ID: 16026107
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.
    Maccari R, Ottanà R.
    J Med Chem; 2015 Mar 12; 58(5):2047-67. PubMed ID: 25375908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.